fenofibrate has been researched along with ubiquinone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bélichard, P; Pruneau, D; Zhiri, A | 1 |
| Burke, V; Croft, KD; Hodgson, JM; Playford, DA; Watts, GF | 1 |
| Burke, V; Croft, KD; Playford, DA; Watts, GF | 1 |
| Cicero, AF; Derosa, G; Gaddi, A; Laghi, L; Miconi, A; Nascetti, S | 2 |
| Asano, A; Inazu, A; Kawashiri, MA; Kobayashi, J; Mabuchi, H; Murase, Y; Nohara, A; Shimizu, M | 1 |
| Beilin, LJ; Burke, V; Chew, GT; Currie, PJ; Davis, TM; Stuckey, BG; Thompson, PL; Watts, GF | 1 |
| Bunjes, H; Roese, E | 1 |
5 trial(s) available for fenofibrate and ubiquinone
| Article | Year |
|---|---|
Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.
Topics: Antioxidants; Blood Glucose; Blood Pressure; Coenzymes; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; F2-Isoprostanes; Female; Fenofibrate; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Oxidative Stress; Ubiquinone | 2002 |
Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes.
Topics: Acetylcholine; Antioxidants; Apolipoprotein A-I; Area Under Curve; Blood Circulation; Blood Pressure; Bradykinin; Cholesterol, HDL; Cholesterol, LDL; Coenzymes; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; F2-Isoprostanes; Female; Fenofibrate; Forearm; Glycated Hemoglobin; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Statistics as Topic; Systole; Treatment Outcome; Triglycerides; Ubiquinone; Vasodilator Agents | 2003 |
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
Topics: Adult; Blood Pressure; Cholesterol; Coenzymes; Creatinine; Drug Resistance; Drug Therapy, Combination; Fatty Acids, Unsaturated; Female; Fenofibrate; gamma-Glutamyltransferase; Humans; Hypertriglyceridemia; Lipoprotein(a); Male; Middle Aged; Time Factors; Treatment Outcome; Triglycerides; Ubiquinone; Uric Acid | 2005 |
Effects of fenofibrate therapy on plasma ubiquinol-10 and ubiquinone-10 levels in Japanese patients with hyperlipidemia and type 2 diabetes mellitus.
Topics: Coenzymes; Diabetes Mellitus, Type 2; Disease Progression; Female; Fenofibrate; Humans; Hyperlipidemias; Male; Middle Aged; Prospective Studies; Ubiquinone | 2006 |
Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction.
Topics: Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diastole; Double-Blind Method; Echocardiography; Female; Fenofibrate; Heart Rate; Humans; Hypolipidemic Agents; Male; Middle Aged; Placebos; Ubiquinone; Ventricular Dysfunction, Left | 2008 |
3 other study(ies) available for fenofibrate and ubiquinone
| Article | Year |
|---|---|
Effect of a long-term treatment with lovastatin or fenofibrate on hepatic and cardiac ubiquinone levels in cardiomyopathic hamster.
Topics: Animals; Body Weight; Cardiomyopathies; Cricetinae; Female; Fenofibrate; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Male; Mesocricetus; Myocardium; Ubiquinone | 1993 |
Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10?
Topics: Adult; Blood Pressure; Cholesterol; Coenzymes; Creatinine; Diet; Drug Resistance; Fatty Acids, Omega-3; Female; Fenofibrate; gamma-Glutamyltransferase; Humans; Hypertriglyceridemia; Lipoprotein(a); Male; Middle Aged; Triglycerides; Ubiquinone; Uric Acid | 2005 |
Drug release studies from lipid nanoparticles in physiological media by a new DSC method.
Topics: alpha-Tocopherol; Animals; Blood; Calorimetry, Differential Scanning; Crystallization; Drug Carriers; Drug Liberation; Emulsions; Fenofibrate; Lactones; Nanoparticles; Orlistat; Rapeseed Oil; Swine; Triglycerides; Ubiquinone | 2017 |